Novartis | NVS - Market Capitalization


Novartis reported $337.69B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Amgen USD 201.45B 25.2B Feb/2026
AstraZeneca USD 222.33B 65.82B Feb/2026
Bausch Health Companies USD 2.99B 417.38M Feb/2026
Biogen USD 27.01B 1.19B Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Canopy Growth CAD 136.67M 644.68M Feb/2026
Corcept Therapeutics USD 3.7B 5.05B Feb/2026
Drreddys Laboratories INR 2.28B 9.41B Feb/2026
Eli Lilly USD 1.01T 3.37B Feb/2026
Gilead Sciences USD 183.59B 31.31B Feb/2026
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
Glaxosmithkline GBP 106.96B 20.08B Feb/2026
J&J USD 500.24B 67.44B Dec/2025
Merck USD 300.37B 39.11B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Novartis USD 303.91B 57.84B Feb/2026
Pacira USD 1.16B 51M Sep/2025
Perrigo USD 2.95B 698M Sep/2025
Pfizer USD 152.89B 11.32B Feb/2026
Phibro Animal Health USD 469M 48M Dec/2023
Prestige Brands USD 3.26B 289M Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Sanofi EUR 118.94B 1.6B Feb/2026
Supernus Pharmaceuticals USD 2.78B 226M Feb/2026
Zoetis USD 57.53B 2.08B Feb/2026